Strata Critical Medical (SRTA) Short-term Investments (2020 - 2026)

Strata Critical Medical has disclosed Short-term Investments across 7 years of filings, most recently posting $66000.0 for Q1 2026.

• In Q1 2026, Short-term Investments fell 99.92% year-over-year to $66000.0; the TTM figure through Mar 2026 stood at $66000.0 (down 99.92% YoY), while the FY2025 annual figure was $30.3 million, down 72.17% from the prior year.
• Short-term Investments eased to $66000.0 in Q1 2026, from $30.3 million in the prior quarter.
• Over the last five years, Short-term Investments for SRTA reached as high as $266.6 million in Q1 2022 and fell as low as $66000.0 in Q1 2026.
• The 5-year median for Short-term Investments is $115.6 million (2024), against an average of $109.3 million.
• Annual changes were most pronounced in 2022 — Short-term Investments soared 10948.73% — and 2026, when it tumbled 99.92%.
• A 5-year view of Short-term Investments shows it stood at $150.7 million in 2022, then slipped by 8.28% to $138.3 million in 2023, then declined by 21.34% to $108.8 million in 2024, then slumped by 72.17% to $30.3 million in 2025, then tumbled by 99.78% to $66000.0 in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $66000.0, $30.3 million, and $53.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.